Moderna to build manufacturing facility
Image: The Hon Daniel Andrews MP, The Hon Anthony Albanese MP, Michael Azrak and Professor Margaret Gardner AC.
Monash University welcomed the The Hon Anthony Albanese MP, The Hon Daniel Andrews MP and Michael Azrak, General Manager of Moderna to sign an agreement with the Victorian government to build its first mRNA production facility in the Southern Hemisphere at Clayton in Melbourne’s south-east, and is expected to produce up to 100 million vaccine doses each year in Australia, including COVID-19, influenza and respiratory syncytial virus (RSV).
Moderna, the Australian Government and the Victorian Government reached an in-principle agreement to build the facility, and will be the world’s first mRNA production facility to be located on a university campus.
Not only will it secure the production of mRNA vaccines on Australian shores and ensure Australians have quick and easy access to vaccines, but it will also boost the country’s medical research and development, clinical trials and global supply chain access.
The Monash Technology Precinct is a place where jobs, opportunity and where people live exist side by side. The Precinct and surrounding cluster contribute nearly $10 billion to the economy and supported 13,000 businesses and 95,000 jobs.